Registration

ALSTON & BIRD LLP for NOVARTIS CORPORATION

Firm
Client
Income
—
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to coverage and reimbursement of pharmaceuticals.

LobbyistCovered position, as disclosed
JENNIFER L BUTLER New —
PETER M KAZON New —
RUDY MISSMAR New —
COLIN ROSKEY New Health Policy Advisor and Counsel, Senate Finance Committee
THOMAS A SCULLY New Administrator & Consultant, CMS; Dep. Asst. to President; Counselor to the Dir., Dir. for Hum. Res. Vets and Labor; Associate Dir. for Legislative Affairs, OMB.

Medical/Disease Research/Clinical Labs MED

Issues related to coverage and reimbursement of pharmaceuticals.

LobbyistCovered position, as disclosed
JENNIFER L BUTLER New —
PETER M KAZON New —
RUDY MISSMAR New —
COLIN ROSKEY New Health Policy Advisor and Counsel, Senate Finance Committee
THOMAS A SCULLY New Administrator & Consultant, CMS; Dep. Asst. to President; Counselor to the Dir., Dir. for Hum. Res. Vets and Labor; Associate Dir. for Legislative Affairs, OMB.

Health Issues HCR

Issues related to coverage and reimbursement of pharmaceuticals.

LobbyistCovered position, as disclosed
JENNIFER L BUTLER New —
PETER M KAZON New —
RUDY MISSMAR New —
COLIN ROSKEY New Health Policy Advisor and Counsel, Senate Finance Committee
THOMAS A SCULLY New Administrator & Consultant, CMS; Dep. Asst. to President; Counselor to the Dir., Dir. for Hum. Res. Vets and Labor; Associate Dir. for Legislative Affairs, OMB.

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
NOVARTIS AG Switzerland Switzerland 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.